Bioventus (BVS) Return on Sales Growth (3y) (2023 - 2026)

Bioventus (BVS) Return on Sales Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Abbott Laboratories 183.80 Bn 176.50 Bn 6.27 Bn 0.00
2 Stryker 128.84 Bn 125.96 Bn 3.81 Bn 0.00
3 Medtronic 108.59 Bn 99.37 Bn 6.41 Bn 0.00
4 Boston Scientific 68.51 Bn 67.06 Bn 3.61 Bn 0.00
5 Edwards Lifesciences 48.18 Bn 44.51 Bn 1.29 Bn 0.00
6 Dexcom 28.40 Bn 27.28 Bn 750.30 Mn 0.00
7 GE HealthCare Technologies 28.16 Bn 25.88 Bn 1.98 Bn 0.00
8 Smith & Nephew 26.89 Bn 26.31 Bn - -
9 Koninklijke Philips 24.66 Bn 21.54 Bn 2.07 Bn 0.00
10 Bioventus 825.73 Mn 789.88 Mn 90.77 Mn 1.00

Historic Data

Download Data
DateValue
Mar 28, 2026 1.00
Dec 31, 2025 0.00
Sep 27, 2025 0.00
Jun 28, 2025 0.00
Mar 29, 2025 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jul 1, 2023 0.00
Apr 1, 2023 -1.00